GMI-based biosensor for the detection and quantification of doxorubicin anticancer drugs labeled to Fe 3 O 4 superparamagnetic nanoparticles

Gokhan Kirat,Ali Erdoğan,Mehmet Ali Aksan
DOI: https://doi.org/10.1016/j.sna.2024.115400
IF: 4.291
2024-04-28
Sensors and Actuators A Physical
Abstract:We present the results of research on a Co-based giant magnetoimpedance (GMI) biosensor for Fe 3 O 4 -labelled doxorubicin (DOX) anticancer drugs. Co 62 Fe 5 Ni 4 Si 15 B 14 ribbons were used as biosensing material for test solutions containing different concentrations of DOX. The plain ribbon, ribbon+Fe 3 O 4 and ribbon+DOX2 samples exhibited low coercivity ( H c ), high saturation magnetization ( M s ) and low anisotropy ( H k ). The GMI ratio (Δ Z / Z ) increased from 33% to 38% with the increase of doxorubicin content in the ribbon. It was found that the Δ Z / Z ratio first increased rapidly up to a frequency of ~2 MHz, and then decreased slowly as the frequency increased. While the magnetic field dependent Δ Z / Z has a single peak at 1 MHz, it has a double peak at 5 MHz. It was found that the peak height of ΔZ/Z in the ribbons with test solution of 20 ng/ml and 50 ng/ml increased by ~3% and ~6%, respectively, compared to the ribbon without test solution. Then the Δ Z / Z ratio decreased very rapidly with the increase of the applied external magnetic fields. The frequency-dependent GMI sensitivity (η) increased with increasing frequency and reached a maximum value at a critical frequency (~1.6 MHz), after which it decreased. The detection sensitivity of the GMI biosensor ( ξ ) increased rapidly with increasing doxorubicin concentration up to ∼80 ng/ml and then remained almost unchanged. The results show that doxorubicin (DOX+Fe 3 O 4 ), used as an anticancer drug, can be effectively detected even at low concentrations using the GMI based sensors fabricated in this study.
engineering, electrical & electronic,instruments & instrumentation
What problem does this paper attempt to address?